Initial results from a first-in-human study show that PET imaging with PD-L1 antibodies outperforms immunohistochemistry- or RNA-sequencing-based biomarkers for prediction of clinical response to immunotherapy.
- Frederike Bensch
- Elly L. van der Veen
- Elisabeth G. E. de Vries
